# Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting

> **NCT06678191** · — · RECRUITING · sponsor: **Chiesi Hungary Ltd.** · enrollment: 800 (estimated)

## Conditions studied

- Asthma, Chronic Obstructive Pulmonary Disease (COPD)
- Asthma Bronchiale

## Interventions

- **DRUG:** BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg

## Key facts

- **NCT ID:** NCT06678191
- **Lead sponsor:** Chiesi Hungary Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-24
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678191, "Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06678191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*